Login / Signup

Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.

Ximena GarcíaAndrés ElíaLucrecia GalizziMaría MayEunice SpenglerPaula Martínez VázquezJavier BurruchagaHugo GassClaudia LanariCaroline A Lamb
Published in: Breast cancer research and treatment (2020)
These data suggest that targeting AR in ER+PR- tumors may represent a promising therapeutic alternative in hormonal refractory tumors.
Keyphrases
  • estrogen receptor
  • poor prognosis
  • binding protein
  • electronic health record
  • big data
  • drug delivery
  • machine learning
  • breast cancer risk